Tata Elxsi & Dräger Collaborate to Drive Critical Care Innovation in India

The collaboration between Tata Elxsi and Dräger aims to fast-track the development of cost-effective, high-quality medical devices.

Tata Elxsi and Dräger, a global leader in medical and safety technology, have joined hands to advance critical care innovation in India.

As part of this collaboration, Dräger is expanding its R&D presence by establishing a new Offshore Development Center (ODC) at Tata Elxsi's facility in Pune.

Pankaj Madhukar Wani, head, Healthcare & Life Sciences Business at Tata Elxsi, highlighted the unique opportunity presented by working alongside Dräger to integrate innovative technology, design, and engineering proficiency into product development.

"Our experience of working across AI-enabled healthcare devices, smart assistive devices, diagnostic devices, injectables, telehealth, and point-of-care devices to name a few, puts us in a unique position to reimagine healthcare models and tackle some critical challenges faced by the healthcare industry today," Wani said.

Wani further emphasized that the collaboration between Tata Elxsi and Dräger is a testament to their joint commitment to healthcare innovation across the development cycle.

The ODC will focus on developing innovative critical care medical devices for both local and international markets, leveraging Tata Elxsi's design and technology expertise alongside Dräger's proficiency in medical and safety technology.

Fostering Innovation in Critical Care

The development center, located at Tata Elxsi's Pune facility, will serve as a central hub for designing and developing innovative critical care medical devices for deployment in operation theatres (OT) worldwide.

This collaboration aims to push the boundaries of medical innovation by adhering to the highest safety and efficacy standards for critical care settings.

Further, the ODC will bring together talent from both organizations to oversee all aspects of critical care product development, from conceptualization to product design, prototyping, and testing.

The ODC provides a comprehensive critical care equipment testing facility equipped with medical-grade gases, compressors, and oxygen cylinders to create a test environment that meets the demanding requirements of the OT setup.

This facility ensures that the developed medical devices undergo rigorous testing to ensure their reliability and safety before deployment in critical care settings.

Strategic R&D Expansion

The collaboration between Tata Elxsi and Dräger aims to fast-track the development of cost-effective, high-quality medical devices, contributing to a robust healthcare ecosystem accessible to everyone.

This partnership underscores Indian R&D capabilities on the global stage and marks Dräger's second R&D center in India, highlighting its commitment to Indian innovation and manufacturing capabilities.

On the partnership, Shalin Patel, MD, Draeger India Group, said, "By leveraging Tata Elxsi's ecosystem and expertise in technology and design, we are setting new standards in critical care equipment that will ultimately benefit patients worldwide.’’

The collaboration, according to him, is a strategic step towards harnessing this potential to develop next-generation critical care solutions.

The ODC, poised to play a pivotal role in innovative healthcare equipment development, reflects India's potential as a global R&D hub. Plans are in place to expand the critical care portfolio, with the ODC positioned to address the evolving needs of patients and healthcare providers globally.

With a shared commitment to leveraging technology and expertise, the partnership aims to deliver transformative solutions that enhance patient care and advance the healthcare industry as a whole.